Genmab A/S (GMAB) Reports FY EPS of $15.37
Tweet
Share
E-mailGet Alerts GMAB Hot Sheet
Join SI Premium – FREE
Genmab A/S (NASDAQ: GMAB) reported FY EPS of $15.37. Revenue for the period came in at $3.72 billion.
For earnings history and earnings-related data on Genmab A/S (GMAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
- JPMorgan Upgrades IBM (IBM) to Overweight
- Texas Capital Securities Downgrades Arcosa (ACA) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
